Open Access Journal of Clinical Trials is an international, peer-reviewed, open access, online journal principally concerned with clinical trial methodology.
Specific topics covered by the journal include:
• Clinical Data Management • Clinical Trial Logistics and Conduct Research • Electronic Health Record Technology • Immunotherapy Combinations with Drug Management • Factor XI Inhibitor Research • Post-Trial Effectiveness Considerations
When considering submission of a paper, authors should ensure that such studies add significantly to the body of knowledge about a clinical trial and its outcomes.
Publishing original research, reports, editorials, reviews and commentaries on all aspects of clinical trial design, management, legal, ethical and regulatory issues, case record form design, data collection, quality assurance and data auditing methodologies.
The Open Access Journal of Clinical Trials will no longer consider meta-analyses for publication.
Journal metrics
Usage
10K annual downloads/views
Citation metrics
1.4 (2023) Impact Factor
1.6 (2023) 5 year IF
3.9 (2023) CiteScore (Scopus)
Q1 CiteScore Best Quartile
0.303 (2023) SNIP
0.561 (2023) SJR
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors
who are deciding where to submit their next manuscript for publication.
However, any one metric only tells a part of the story of a journal’s
quality and impact. Each metric has its limitations which means that it
should never be considered in isolation, and metrics should be used to
support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside
other qualitative factors such as a journal’s aims & scope, its
readership, and a review of past content published in the journal. In
addition, a single article should always be assessed on its own merits and
never based on the metrics of the journal it was published in.
Usage and acceptance rate data above are for the last full calendar year
and are updated annually in February. Speed data is updated every six
months, based on the prior six months. Citation metrics are updated
annually mid-year. Please note that some journals do not display all of
the following metrics
(find out why).
Usage:
the total number of times articles in the journal were viewed by users
of Taylor & Francis Online in the previous calendar year, rounded to the
nearest thousand.
Citation Metrics
Impact Factor*:
the average number of citations received by articles published in the
journal within a two-year window. Only journals in the Clarivate Science
Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI),
Arts and Humanities Citation Index (AHCI) and the Emerging Sources
Citation Index (ESCI) have an Impact Factor.
Impact Factor Best Quartile*:
the journal’s highest subject category ranking in the Journal Citation
Reports. Q1 = 25% of journals with the highest Impact Factors.
5 Year Impact Factor*:
the average number of citations received by articles in the journal
within a five-year window.
CiteScore (Scopus)†:
the average number of citations received by articles in the journal over
a four-year period.
CiteScore Best Quartile†:
the journal’s highest CiteScore ranking in a Scopus subject category. Q1
= 25% of journals with the highest CiteScores.
SNIP
(Source Normalized Impact per Paper):
the number of citations per paper in the journal, divided by citation
potential in the field.
SJR
(Scimago Journal Rank):
Average number of (weighted) citations in one year, divided by the
number of articles published in the journal in the previous three years.
Speed/acceptance
From submission to first decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision. Based on manuscripts receiving a
first decision in the last six months.
From submission to first post-review decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision if it is sent out for peer review.
Based on manuscripts receiving a post-review first decision in the last
six months.
From acceptance to online publication:
the average (median) number of days from acceptance of a manuscript to
online publication of the Version of Record. Based on articles published
in the last six months.
Acceptance rate:
articles accepted for publication by the journal in the previous
calendar year as percentage of all papers receiving a final decision.
Professor Arthur Frankel, Chief of Hematology/Oncology, West Palm Beach VA Medical Center, United States
Editorial Board:
Professor Abdelhamid Attia, Obstetrics and Gynecology, Faculty of Medicine, Cairo University, Egypt
Dr Adam M Brufsky, Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh, United States
Professor Rudy Castellani, Pathology, Center for Neuropathology, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, United States
Professor Mario Cazzola, Experimental Medicine and Surgery, University of Rome Tor Vergata, Italy
Dr William Checkley, Division of Pulmonary and Critical Care, Johns Hopkins University, United States
Professor E. David Crawford, Urology, University of San Diego, Koman Family Outpatient Pavilion, Denver, CO, United States
Prof. Dr. Tarek El-Bialy, Dentistry and Biomedical Engineering, University of Alberta, Canada
Professor Stephen Gitelman, Clinical Pediatrics, University of California, United States
Dr Robert A Hauser, Neurology, USF Parkinson's Disease and Movement Disorders Center, Parkinson Foundation Center of Excellence, FL, United States
Dr Mallory Johnson, Department of Medicine, University of California, San Francisco, United States
Professor Roger S. McIntyre, Psychiatry and Pharmacology, University of Toronto, and Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada
Dr Ian S. Zagon, Neural & Behavioural Sciences, Pennsylvania State University, United States
Abstracting and indexing
Open Access Journal of Clinical Trials is indexed/tracked/covered by the following services:
Directory of Open Access Journals (DOAJ)
EMBASE (Elsevier)
Pubmed (NLM)
PubMed Central Selective Deposit Medicine & Health (NLM)
Scopus (Elsevier)
Open access
Open Access Journal of Clinical Trials is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
Increase the discoverability and readership of your article
Make an impact and reach new readers, not just those with easy access to a research library
Freely share your work with anyone, anywhere
Comply with funding mandates and meet the requirements of your institution, employer or funder
Rigorous peer review for every open access article
Article Publishing Charges (APC)
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/110803/Subject-Sample-2021-Bioscience.jpg"})